Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-4-20
pubmed:abstractText
Cardiovascular system dysregulation in the form of autonomic dysfunction is common at all stages of the disease process in the autoimmune liver disease primary biliary cirrhosis (PBC) and associates with the symptom of fatigue. The mechanisms underpinning autonomic dysfunction in PBC are, however, at present unclear. In this study we set out to explore, for the first time, cardiac structure and function in PBC using impedance cardiography (ICG) and magnetic resonance methodologies. ICG was assessed beat to beat in response to orthostasis (by head-up tilt) in age and sex case-matched high-fatigue and low-fatigue PBC groups (assessed by Fatigue Impact Scale), normal control subjects (n = 15 each group) and a liver disease control cohort (primary sclerosing cholangitis). Cardiac structure and bioenergetics were examined in 15 of the PBC subjects and 8 of the normal control subjects by magnetic resonance spectroscopy and cine imaging. Capacity of the left ventricle to respond to orthostasis [left ventricular ejection time (LVET)] was impaired in PBC compared with matched normal control subjects (P = 0.05). This was a PBC-specific phenomenon unrelated to fatigue status. PBC patients exhibited significantly lower cardiac muscle phosphocreatine-to-ATP ratio (PCr/ATP ratio; measure of cardiac bioenergetic integrity) compared with control subjects (P < 0.01). PCr/ATP <1.6 (indicative of increased risk of death in cardiomyopathy) was present in 6/15 (40%) PBC patients (0/8 control subjects; P < 0.05). Cardiac structure and function were similar in all measures of left ventricular morphology between control subjects and PBC. The close relationship between PCr/ATP and LVET seen in normal subjects (r(2) = 0.6; P < 0.05) was lost in PBC patients, a finding compatible with myocardial dysfunction. Significant correlation was seen between fatigue severity in PBC and fall in cardiac output on orthostasis (r(2) = 0.25; P = 0.005). Our findings suggest the presence of altered myocardial function in PBC. Autonomic "dysfunction" may, rather than being an abnormal process, represent a compensatory mechanism to increase cardiac return to mitigate these effects.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-10517916, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-10735604, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-10796879, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-11124815, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-11357949, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-11458702, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-11751653, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-12117892, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-12360466, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-12810608, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-12920435, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-15824263, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-16177849, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-16353438, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-16448458, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-17272997, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-17538969, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-17685473, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-17955548, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-18691944, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-19240290, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-19602135, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-7699249, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-8259055, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-9264448, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-9279616, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-9337189, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-9591766, http://linkedlifedata.com/resource/pubmed/commentcorrection/20133949-9651739
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1522-1547
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
298
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
G764-73
pubmed:dateRevised
2011-7-28
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Impaired cardiovascular function in primary biliary cirrhosis.
pubmed:affiliation
Institute of Cellular Medicine, Newcastle Univ., UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't